0:00 Indian equity markets added more than twelve hundred points to the Sensex on Tuesday, marking a decisive four-day turnaround after months of heavy capital flight.0:11 In our previous episode, we tracked the coastal disruption of Cyclone Murasu; across the financial centres, however, the economic weather has shifted just as abruptly.0:22 Foreign portfolio investors dumped over one point five nine lakh crore rupees in domestic equities between April and early November.0:32 Yet on Tuesday, the Nifty surged three hundred and seventy points to cross twenty-three thousand eight hundred, driven by an eleven percent slide in Brent crude prices and renewed institutional buying.0:46 It's a remarkable story of domestic resilience meeting sudden geopolitical relief.0:51 The question, of course, is whether a retreat in oil to a hundred and five dollars a barrel can permanently reverse the outflow, but for now, the immediate pressure on the rupee has eased.1:04 Meanwhile, New Delhi is preparing a structural shift for India's rapidly expanding digital labour market.1:12 The central government is actively considering a two percent levy per transaction on platform aggregators, rather than taxing overall turnover, to fund social security benefits for more than twelve million gig workers.1:27 That workforce expanded by fifty-five percent over the past five years.1:32 Official projections from Niti Aayog estimate it will reach twenty-three point five million people by twenty-thirty, contributing more than two lakh crore rupees to national output.1:44 Shifting the levy to individual transactions is designed to create a direct, ring-fenced funding pipeline for healthcare and accident cover without crippling platform margins.1:57 And yet, that's not the whole picture.1:59 The policy signals that the state no longer views algorithmic delivery work as an informal stopgap, but as permanent infrastructure requiring mandatory corporate underwriting.2:12 At the same time, the Union health ministry has published draft amendments to tighten manufacturing accountability across the pharmaceutical sector.2:22 Under the proposed changes to the Drugs Rules, every drugmaker must formally designate a qualified expert specifically responsible for batch releases, accompanied by a mandatory certificate for every lot entering the market.2:37 Previously, firms declared technical personnel overseeing general manufacturing, but avoided assigning individual liability for final distribution.2:48 Today's developments reflect a clear recalibration across regulation and finance: institutional capital is trickling back, while the state demands formal accountability from both tech platforms and factory floors.
